Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
Qiang Xiao(University of Toronto), Patricia L. Brubaker(University of Toronto), Maria Cino, Robin P. Boushey(University of Ottawa), Daniel J. Drucker(University of Toronto)
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
April 1, 2000
Cited by 109
Related Papers
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
|Clinics in Colon and Rectal Surgery|2009|2k
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
|Diabetes Care|2003|578
Practice Parameters for the Management of Rectal Cancer (Revised)
|Diseases of the Colon & Rectum|2013|565